Thursday, October 05, 2006

Update on gigs

I will soon fill y'all in on who is now playing where in the post- Clint era. I suffered a total PC hard drive crash last week and have been limping along on my work laptop ever since. Yesterday we installed new his & hers 20" iMacs at home (they are fabulous!) and I'm still installing peripherals and software and retrieving emails. So, stay tuned.

- BobbyG

From my friend the jazz genius Ronnie Foster:
People, First of all I would like to thank everyone for their support with our Artisan situation, we did feel the love thanks.Out with the old in with the new.We've found a very cool spot to play not a bad seat in the house nice tables more of a restaurant vibe, seats about 150 people and has great Mediterranean Cuisine and Hookahs, hmmm….The Place:

Cedar's Grill 3655 S Durango Dr, Las Vegas, NV between Twain and Spring Mountain Rd. Right behind Brewskies.
Next: Jamie Hosmer is appearing Wed and Thurs evenings from 6 - 11 pm at "Hanks" at Green Valley Station in Henderson, and Sunday evenings at Red Rock Station (exact venue TBA).

Also, bassist David Inamine informs me of a free lakeside gig Friday Oct 6th at Lake Las Vegas in which he will be featured with L. A. jazz keboardist David Garfield.

More to come...


Joe's new percussion website,, is now up. Check it out.

WASHINGTON, (Reuters) -- Good news for aging hippies: Smoking pot may stave off Alzheimer's disease.

New research shows that the active ingredient in marijuana may prevent the progression of the disease by preserving levels of an important neurotransmitter that allows the brain to function.

Researchers at the Scripps Research Institute in California found that marijuana's active ingredient, delta-9-tetrahydrocannabinol, or THC, can prevent the neurotransmitter acetylcholine from breaking down more effectively than commercially marketed drugs.

THC is also more effective at blocking clumps of protein that can inhibit memory and cognition in Alzheimer's patients, the researchers reported in the journal Molecular Pharmaceutics...
But, but, but... does this mean I should resume therapy after all these decades?


No comments: